Total synthesis of tubastrine and 3-dehydroxy tubastrine by microwave-assisted cross-coupling reactions by Lorentzen, Marianne et al.
1	  
	  
Total synthesis of tubastrine and 3-dehydroxy tubastrine by 
microwave-assisted cross-coupling reactions 
Marianne Lorentzen,a Annette Bayer,b Magne O. Sydnesa* and Kåre B. Jørgensena* 
a Department of Mathematics and Natural Science, Faculty of Science and Technology, 
University of Stavanger, NO-4036 Stavanger, Norway 
b Department of Chemistry, Faculty of Science and Technology, UiT The Arctic University of 
Norway, NO-9037 Tromsø, Norway 
 
Email: kare.b.jorgensen@uis.no; magne.o.sydnes@uis.no 
Corresponding author contact information: Kåre B. Jørgensen, Faculty of Science and 
technology, University of Stavanger, NO-4036 Stavanger, Norway. Phone: +47 51832306, 
Fax: +47 51831750, E-mail: kare.b.jorgensen@uis.no  
Graphical abstract: 
 
ABSTRACT: The first syntheses of tubastrine and 3-dehydroxy tubastrine are described. The 
target compounds were prepared in four consecutive steps from commercially available 
starting materials. The central scaffold was formed by a microwave-assisted C-N cross-




iodovinyl)phenoxy)–dimethylsilane, respectively. The aryl vinyl iodides were obtained by a 
Hunsdiecker-Borodin-type reaction of aryl acrylic acids, which were easily available from 
trans-caffeic acid or trans-p-coumaric acid. 
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Tubastrine (1), and 3-dehydroxy tubastrine (2), shown in Figure 1, are two guanidine 
containing natural products. The former was first isolated from the coral Tubastrea aurea by 
Sakai et al. in 1987.1 In recent years tubastrine has also been found in a Dendrodoa specie, 
Dendrodoa grossularia, and the ascidian Ascidiella scabra, both collected from the Orkney 
Islands,2 as well as in a New Zealand ascidian, Aplidium orthium.3 Tubastrine showed 
antiviral,1 anticancer, antimicrobial2 and anti-inflammatory activity,3 making it an interesting 
starting point for further SAR studies. 3-Dehydroxy tubastrine, in turn, has been isolated from 
an Australian marine sponge, Spongosorites sp.,4 as well as in the sub-arctic ascidian, 
Dendrodoa aggregate5 and displayed antimicrobial activity against several bacteria such as 





Figure 1. Tubastrine (1), and 3-dehydroxy tubastrine (2) 
 
To the best of our knowledge, tubastrines 1 and 2 have not yet been synthesized. One 
attempt to prepare compound 2 has been reported in the literature, however, the synthesis 
failed in the final step.6 Our endeavor into the tubastrines, motivated by their biological 
activity, required a convergent approach that could easily generate analogous compounds. 
Two obvious disconnections could be envisioned (Scheme 1). Disconnection A corresponds 
to a Heck cross-coupling reaction7 between the respective aryl halides and protected 
vinylguanidines, while disconnection B corresponds to a C-N cross-coupling reaction8 
between the respective aryl vinyl halides and protected guanidines. In the following, we 
present the first synthesis of tubastrine (1) and 3-dehydroxy tubastrine (2) following the above 
outlined strategy. 
 
Scheme 1.	  Retrosynthetic analysis of tubastrine (1) and 3-dehydroxy tubastrine (2). 
 
2. Results and discussion 
4	  
	  
Initial studies concentrated on the approach corresponding to disconnection A 
(Scheme 1). To begin with, methyl acrylate was used as a model for vinylguanidine (route A) 
in a Heck cross-coupling reaction7 with 4-bromoveratrol 3 to provide ester 4 (Scheme 2) 
similar to previously reported couplings.9 Later it became evident that vinylguanidine was not 
available to us in spite of several attempts from different starting points.* We therefore turned 
our attention to the alternative approach employing the C-N cross-coupling reaction8 of the 
respective aryl vinyl halides and protected guanidines (Scheme 1, route B). 
 
 	  
Scheme 2. Reagent and conditions: (a) Methyl acrylate (1 equiv.), Pd(OAc)2 (5 mol%), P(o-
tolyl)3 (10 mol%), Et3N (2 equiv.), MeCN, MW (100W), 110 °C, 45 min, 81% (b) NaOH (2 
equiv.), MeOH : H2O (10:1), 60 °C, 18 h, 77%; (c) NBS / NIS (1 equiv.), LiOAc (0.2 equiv.), 
MeCN : H2O (19:1), rt, 1 h, 83% (6) / 80% (7a).  
 
The aryl vinyl halides were obtained by a Hunsdiecker-Borodin-type 
decarboxylation/halogenation reaction10 of aryl acrylic acids (Scheme 2). Treatment of acid 
5a with N-bromosuccinimide (NBS) or N-iodosuccinimide (NIS) gave the corresponding aryl 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
*	  In	  the	  early	  stages	  of	  this	  project,	  vinylguanidine	  was	  listed	  as	  commercially	  available	  in	  Scifinder®,	  but	  the	  
source	  turned	  out	  to	  be	  a	  custom	  synthesis	  company	  that	  did	  not	  have	  the	  compound	  in	  stock.	  No	  
straightforward	  synthesis	  of	  this	  compound	  was	  found.	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vinyl bromide 6 and -iodide 7a in 83% and 80% yields, respectively. Acid 5a was either 
obtained by hydrolysis of ester 4 with NaOH in methanol/water in 77% isolated yield 
(Scheme 2) or from commercial sources.	  
Next, a C-N cross-coupling reaction11 between 1,3-bis(tert-butoxycarbonyl)guanidine 
(8) and either aryl vinyl bromide 6 or aryl vinyl iodide 7a forming the protected tubastrine 
precursor 9a was investigated. Using different conditions (ligands, catalyst, heating source, 
solvents, base and reaction time), product 9a was formed in yields as shown in Table 1 and 
Table 2. Microwave-assisted reactions gave improved yields of 9a (49%; Entry 6, Table 1) 
compared to traditional heating using an oil bath at 65 °C (22%; Entry 1, Table 1). The aryl 
vinyl iodide 7a performed better in the cross-coupling reaction (Entries 6 and 7, Table 1) than 
the aryl vinyl bromide 6 (Entries 2, 3 and 5, Table 1). A stoichiometric amount of CuI was 
necessary for the reaction to occur (Entries 1-3 and 5-7, Table 1). Catalytic amounts of CuI 
gave no trace of product as observed by TLC analysis. A number of ligands were tested (see 
Table 1). N,N′-Dimethylethylenediamine (DMEDA, L1) (Entries 1,3 and 5-7, Table 1) and 
(1R,2R)-(−)-1,2-diaminocyclohexane (L6) (Entry 12, Table 1) promoted the cross-coupling 
reaction, while L-proline (L2), trans-4-hydroxy-L-proline (L3),	  N,N-diethylsalicylamide (L4), 
N-(2-hydroxybenzoyl)pyrrolidine (L5) and 1,10-phenanthroline (L7) gave no trace of product 
(Entries 8-11, Table 1). No product was observed when CuI was used as catalyst without 
ligands (Entry 14, Table 1). The ideal reaction time was found to be 35 min (Entries 2, 5-7 
and 12, Table 1), since longer reaction time decreased the yield of product 9a (Entry 3, Table 
1). 















1 7a 1.5 L1 (2.2) 18 (h)b 22 
2 6 1 L1 (2.2) 35 34 
3 6 1 L1 (2.2) 60 24 
4 6 1 L1 (0.2) 35 nr 
5 6 1.5 L1 (2.2) 35 29 
6 7a 1.5 L1 (2.2) 35 49 
7 7a 2 L1 (2.2) 35 53 
8 7a 1.5 L2 (2.2) 35 nr 
9 7a 1.5 L3 (2.2) 35 nr 
10 7a 1.5 L4 (2.2) 35 nr 
11 7a 1.5 L5 (2.2) 35 nr 
12 7a 1.5 L6 (2.2) 35 30 
13 7a 1.5 L7 (2.2) 35 nr 
14 7a 1.5 - 35 nr 
aIsolated yield. bTraditional heating (oil bath). 	  
The cross-coupling reaction was also tested with different solvents (THF, toluene, 
CH2Cl2 or MeCN), copper sources (CuI, CuOAc, Cu(OAc)2 or CuCl) and bases (K3PO4, 
Cs2CO3, K2CO3 or Et3N). The amount of base was important for the yield. Two equivalents of 
K3PO4 gave higher yield of product 9a (Entries 1 and 3, Table 2) than one equivalent (Entry 2, 
Table 2), while four equivalents gave a significant decrease in the yield of product 9a (Entry 
4, Table 2). With K2CO3 or Et3N as base lower yield of compound 9a was obtained (Entries 5 
and 7, Table 2), while Cs2CO3 gave approximately the same yield as with K3PO4 (Entry 6, 
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Table 2). Changing solvent from MeCN to THF, toluene or CH2Cl2 was not beneficial for the 
cross-coupling reaction. Only trace amounts of product were observed using toluene or 
CH2Cl2 as solvent (Entries 9 and 10, Table 2), while a 19% yield of product 9a was obtained 
with THF (Entry 8, Table 2). With CuOAc or CuCl only trace amounts of product were 
observed by TLC analysis (Entries 11 and 13, Table 2), while Cu(OAc)2 did not promote the 
reaction in any way (Entry 12, Table 2). 






Solvent Yield (%) 
of 9aa 
1 CuI  K3PO4 (2) MeCN 34b 
2 CuI  K3PO4 (1) MeCN 26b 
3 CuI  K3PO4 (2) MeCN 49 
4 CuI  K3PO4 (4) MeCN 29 
5 CuI  K2CO3 (2) MeCN 39 
6 CuI  Cs2CO3 (2) MeCN 45 
7 CuI  Et3N (2) MeCN 29 
8 CuI  K3PO4 (2) THF 19 
9 CuI  K3PO4 (2) Toluene trace 
10 CuI  K3PO4 (2) CH2Cl2 trace 
11 CuOAc  K3PO4 (2) MeCN trace 
12 Cu(OAc)2c K3PO4 (2) MeCN nr 
13 CuCl  K3PO4 (2) MeCN trace 




Typical side products observed in the cross-couplings were 1,2-dimethoxy-4-
vinylbenzene and (E)-tert-butyl 3,4-dimethoxystyrylcarbamate, which accounted for 
approximately 20-25% of the starting material 7a. Under most of the reaction conditions 
tested, the reaction did not go to completion. However, longer reaction time only resulted in a 
decreased yield of product 9a and an increased yield of (E)-tert-butyl 3,4-
dimethoxystyrylcarbamate. Less (E)-tert-butyl 3,4-dimethoxystyrylcarbamate was isolated 
when using K3PO4 as base compared to Cs2CO3. In addition, trace amounts of several other 
side products were observed by TLC and 1H NMR analysis of the crude reaction mixture, but 
these products were difficult to isolate. 
Next, the 3-dehydroxy tubastrine precursor 9b was prepared employing the optimized 
conditions for the formation of 9a (Scheme 3). (E)-1-(2-Iodovinyl)-4-methoxybenzene (7b) 
was obtained from commercially available (E)-3-(4-methoxyphenyl)acrylic acid (5b) after 
treatment with NIS at room temperature for 1 h to yield product 7b in 74% yield. The cross-
coupling of substrate 7b with guanidine 8 using either K3PO4, or Cs2CO3 as base, resulted in 
the formation of product 9b. For the reaction using K3PO4 as base substrate 9b was formed in 
45% yield. In addition, the corresponding product with a Boc group on the internal N atom 
instead of one of the terminal N atoms was isolated in 13% yield, thus giving in total 58% 
yield of isomers relevant for the synthesis of target compound 2. Utilizing Cs2CO3 as base 





Scheme 3. Reagent and conditions: (a) NIS (1 equiv.), LiOAc (0.2 equiv.), MeCN : H2O 
(19:1), rt, 1 h, 74%; (b) 8 (1.5 equiv.), CuI (1.1 equiv.), DMEDA (2.2 equiv.), base (2 equiv), 
MeCN, MW (50 W), 65 °C, 35 min, with K3PO4, 45%, or with Cs2CO3, 50%. 
 
The Boc groups in compound 9a and 9b were easily removed using TFA at 100 °C 
(microwave) for 20 min. The removal of the methoxy groups in substrate 9a and 9b was more 
difficult than first anticipated. Treatment with BBr3 gave an intractable mixture of products, 
while a premixture of NaI and TMSCl12 was inefficient in the removal of the methoxy groups. 
Due to the difficulties with the final deprotection of substrate 9a and 9b, the corresponding 
tert-butyldimethylsilyl (TBDMS) protected analogues were envisioned to be better precursors 
for target compounds 1 and 2. 
The TBDMS protected analogues 9c and 9d were prepared by the established strategy 
(Scheme 4). Commercially available trans-caffeic acid (10) and p-coumaric acid (11) were 
silylated with TBDMSCl / Et3N in CH2Cl2, followed by hydrolysis of the silyl ester with 
K2CO3 in methanol/water to afford the protected aryl acrylic acids 5c and 5d in 76% and 44% 
yields.10b,13 The Hunsdiecker-Borodin-type reaction10 of 5c and 5d with NIS gave aryl vinyl 
iodides 7c and 7d in 71% and 74% yield, respectively. In the microwave-assisted C-N cross-
coupling reaction with guanidine 8 products 9c and 9d were formed in 45% or 37% yield, 
respectively. The synthesis was completed by desilylation with tetrabutylammonium fluoride 
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(TBAF), followed by a Boc deprotection using TFA, providing target compounds 1 and 2 in 
64% and 61% yield, respectively.  
	  
Scheme 4. Reagent and conditions: (a) (i) Et3N, TBDMSCl, CH2Cl2, rt, 18 h. (ii) K2CO3 (1 
equiv.), MeOH : H2O (1:1), rt, 1 h, 76% (5c) / 44% (5d); (b) NIS (1 equiv.), LiOAc (0.2 
equiv.), MeCN : H2O (19:1), rt, 1 h,71% (6c) / 74% (6d); (c) 8 (1.5 equiv.), CuI (1.1 equiv.), 
DMEDA (2.2 equiv.), K3PO4 (2 equiv), MeCN, MW (50 W), 65 °C, 35 min, 45% (9c) / 37% 
(9d); (d) (i) TBAF, THF, rt, 18 h. (ii) TFA (4.4 equiv.), MeCN, MW, 100 °C, 15 min, 64%. 
(1) / 61% (2). 
3. Conclusion 
The first total synthesis of tubastrine (1) and 3-dehydroxy tubastrine (2) were completed 
utilizing a microwave-assisted C-N cross-coupling reaction between 1,3-bis(tert-
butoxycarbonyl)guanidine (8) and (E)-((4-(2-iodovinyl)-1,2-phenylene)bis(oxy))bis(tert-
butyldimethylsilane) (7c) or (E)-tert-butyl(4-(2-iodovinyl)phenoxy)dimethylsilane, 
respectively (7d). Target compounds 1 and 2 were prepared in four steps from commercial 
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available starting materials with overall yields of 15.5% and 7.3%, respectively. The total 
synthesis opens up for further biological evaluation of the two natural products and analogues 
thereof. 
4. Experimental 
4.1 General  
Acetonitrile (MeCN) was dried over molecular sieves (oven dried) three times, and stored 
over molecular sieves under nitrogen atmosphere. Anhydrous Toluene, THF and CH2Cl2 were 
purchased from VWR and used as received. N,N’-Dimethylethylenediamine (DMEDA) was 
distilled and stored over KOH, the same was Et3N. Copper(I)iodide was recrystallized from 
potassium iodide solution (concentrated) and water, and dried in an oven prior to use. All 
reactions were carried out under argon atmosphere if not otherwise specified. The microwave 
reactions were performed in 10 mL pressure vials with caps using Discover SP from CEM. 
TLC was performed on Merck silica gel 60 F254 plates, using UV light at 254 nm and 5% 
alcoholic molybdophosphoric acid for detection. Normalsil 60, 40-63 µm silica gel was used 
for flash chromatography. Reverse phase purification of compound 1 and 2 were performed 
on g C18 prepacked Isolute® SPE columns. 1H NMR and 13C NMR spectra were recorded on 
a Bruker Avance 400 MHz, all at room temperature. Chemical shifts were reported in ppm 
compared to TMS (δ 0, singlet, for 1H NMR), or for 13C resonance signal to CDCl3 (δ 77.0, 
triplet). The splitting pattern was recorded as a singlet, s; doublet, d; triplet, t; double doublet, 
dd; double triplet, dt; quartet, q; multiplet, m; broad, br. IR was recorded on a Perkin Elmer 
FT-IR spectrometer, version 3.02.01. Melting points were determined on a Stuart Scientific 
melting point apparatus SMP3. High-resolution mass spectra (HRMS) were recorded from 
MeOH solutions on a LTQ Orbitrap XL (Thermo Scientific) in positive or negative 
electrospray ionization (ESI) mode.  
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4.2. (E)-Methyl 3-(3,4-dimethoxyphenyl)acrylate (4) 
4-Bromoveratrol (3) (90 µL, 0.713 mmol), methyl acrylate (130 µL, 1.43 mmol) and Et3N 
(0.2 mL, 1.43 mmol) were added to a pre-stirred solution of Pd(OAc)2 (8 mg, 0.035 mmol) 
and P(o-tolyl)3 (22 mg, 0.070 mmol) in MeCN (2 mL). The mixture was microwave heated 
(150 W, 110 °C) for 45 min, cooled to room temperature and concentrated in vacuo on silica 
gel. The crude product was purified by flash column chromatography (petroleum ether: 
EtOAc 5:1) to afford 133 mg (84%) of product 4 as a white solid. mp 67.9-69.4 °C (hexane), 
lit.14a 68-69 °C. Published data14 were in accordance with ours: 1H NMR (CDCl3, 400 MHz): δ 
7.64 (d, J = 16.0 Hz, 1H), 7.11 (dd, J = 8.3, 2.0 Hz, 1H), 7.05 (d, J = 2.0 Hz, 1H), 6.87 (d, J = 
8.3 Hz, 1H), 6.32 (d, J = 16.0 Hz, 1H), 3.92 (s, 6H), 3.80 (s, 3H); 13C NMR (CDCl3, 100 
MHz): δ 167.6 (CO), 151.1 (C), 149.1 (C), 144.8 (CH), 127.3 (C), 122.6 (CH), 115.4 (CH), 
110.9 (CH), 109.5 (CH), 55.9 (CH3), 55.8 (CH3), 51.6 (CH3); IR (KBr) 2945 (w), 2840 (w), 
1697 (s), 1626 (m), 1596 (m), 1511 (m), 1465 (m), 1440 (m), 1422 (m), 1348 (w), 1254 (s), 
1232 (m), 1162 (m), 1145 (m), 1040 (m), 1022 (m), 984 (m), 870 (w), 857 (w), 815 (w)757 
(w); Mass spectrum m/z (relative intensity %) 245.2 [M+Na]+ (100); HRMS (ESI) Calc. for 
C12H14O4Na: 245.0784, Found 245.0787.  
4.3. (E)-3-(3,4-Dimethoxyphenyl)acrylic acid (5a) 
To a solution of acrylate 4 (1.997 g, 8.98 mmol) in MeOH (50 mL) and water (5 mL) was 
added KOH (715 mg, 17.88 mmol). The reaction mixture was heated to 60 °C for 18 h, before 
concentrated in vacuo. The residue was dissolved in water (50 mL), added 2 M aqueous 
NaOH solution (1 mL) and extracted with Et2O (2 x 60 mL). The water layer was adjusted to 
pH 0 by the addition of 6 M HCl (4 mL) and extracted a second time with CH2Cl2 (5 x 50 
mL).  The latter organic layer was dried over MgSO4, filtered and concentrated in vacuo. The 
crude product was purified by flash column chromatography (petroleum ether: EtOAc 1:2) to 
afford 1.443 g (77%) of product 5a as a white solid. mp 180.7-181.8 °C (hexane), lit.15 181-
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182 °C. Published data15 were in accordance with ours: 1H NMR (CDCl3, 400 MHz): δ 7.74 
(d, J = 15.9 Hz, 1H), 7.14 (dd, J = 8.4, 1.96 Hz, 1H), 7.08 (d, J = 1.92 Hz, 1H), 6.89 (d, J = 
8.4 Hz, 1H), 6.33 (d, J = 15.9 Hz, 1H), 3.93 (s, 6H); 13C NMR (CDCl3, 100 MHz): δ 172.4 
(CO), 151.5 (C), 149.2 (C), 147.0 (CH), 127.0 (C), 123.2 (CH), 114.8 (CH), 111.0 (CH), 
109.7 (CH), 56.0 (CH3), 55.9 (CH3); IR (KBr) 2840 (w), 1683 (s), 1625 (m), 1597 (m), 1517 
(s), 1459 (m), 1427 (m), 1341 (m), 1299 (m), 1265 (s), 1211 (m), 1169 (w), 1142 (s), 1025 
(m), 976 (w), 841 (m), 770 (w); Mass spectrum m/z (relative intensity %) 207.2 [M]- (100); 
HRMS (ESI) Calc. for C11H11O4: 207.0663, Found 207.0663.  
4.4. (E)-3-(3,4-Bis((tert-butyldimethylsilyl)oxy)phenyl)acrylic acid (5c) 
tert-Butyldimethylsilyl chloride (3.396 g, 22.53 mmol) in anhydrous CH2Cl2 (15 mL) was 
added slowly to a precooled solution of trans-caffeic acid (1.196 g, 6.66 mmol) in anhydrous 
CH2Cl2 (15 mL) and Et3N (6.1 mL, 43.74 mmol) at 0 °C. The mixture was warmed to room 
temperature and stirred overnight (18 h), washed with 1 M HCl (2 x 30 mL) and water (30 
mL), dried over MgSO4, filtered and concentrated in vacuo. The brown oil was dissolved in 
MeOH (30 mL) and water (30 mL) before K2CO3 (949 mg, 6.87 mmol) was added. The 
mixture was stirred for 4 h and concentrated in vacuo to half of the volume. EtOAc (50 mL) 
and concentrated HCl (4 mL, pH 0) were added, the phases were separated and the water 
layer was extracted with EtOAc (2 x 50 mL). The combined organic layer was washed with 
brine (100 mL), dried over MgSO4, filtered and concentrated in vacuo. The crude product was 
purified by flash column chromatography (petroleum ether: EtOAc 3:1) to afford 1.979 g 
(73%) of product 5c as a white solid. mp 157.8-158.8 °C (hexane), lit.13 152-155 °C. 
Published data13 were in accordance with ours: 1H NMR (CDCl3, 400 MHz): δ 7.67 (d, J = 
15.9 Hz, 1H), 7.05-7.04 (m, 2H), 6.84 (d, J = 8.8 Hz, 1H), 6.25 (d, J = 15.9 Hz, 1H), 1.00 (s, 
9H), 0.99 (s, 1H), 0.23 (s, 6H), 0.22 (s, 6H); 13C NMR (CDCl3, 100 MHz): δ 172.3 (CO), 
149.9 (C), 147.2 (C), 147.0 (CH), 127.6 (C), 122.7 (CH), 121.2 (CH), 120.6 (CH), 114.7 
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(CH), 125.9 (3xCH3), 25.8 (3xCH3), 18.5 (C), 18.4 (C), ÷4.1(0) (2xCH3), ÷4.1(1) (2xCH3); 
IR (KBr) 2929 (m), 2857 (m), 1679 (m), 1629 (m), 1596 (m), 1507 (s), 1472 (w), 1426 (m), 
1292 (s), 1253 (m), 1202 (m), 1165 (w), 1126 (w), 993 (w), 916 (m), 860 (m), 836 (m), 812 
(w), 781 (m), 679 (w); Mass spectrum m/z (relative intensity %) 431.2 [M+Na]+ (100); HRMS 
(ESI) Calc. for C21H36O4NaSi2: 431.2044, Found 431.2046.  
4.5. (E)-3-(4-((tert-Butyldimethylsilyl)oxy)phenyl)acrylic acid (5d) 
tert-Butyldimethylsilyl chloride (2.452 g, 16.27 mmol) in anhydrous CH2Cl2 (15 mL) was 
added slowly to a precooled solution of trans-p-coumaric acid (1.205 g, 7.31 mmol) in 
anhydrous CH2Cl2 (15 mL) and Et3N (4.5 mL, 32.27 mmol) at 0 °C. The mixture was warmed 
to room temperature and stirred overnight (18 h), washed with 1 M HCl (2 x 30 mL) and 
water (30 mL), dried over MgSO4, filtered and concentrated in vacuo. The brown oil was 
solved in MeOH (30 mL) and water (30 mL) before K3CO3 (1.050 g, 7.60 mmol) was added. 
The mixture was stirred for 4 h and concentrated in vacuo to half of the volume. EtOAc (50 
mL) and concentrated HCl (4 mL, pH 0) was added. The two phases were separated and the 
water layer was extracted with EtOAc (2 x 50 mL). The combined organic layer was washed 
with brine (100 mL), dried over MgSO4, filtered and concentrated in vacuo.  The crude 
product was purified by flash column chromatography (petroleum ether: EtOAc 3:1) to afford 
887 mg (44%) of product 5d as a white solid. mp 129.4-130.4 °C (hexane), lit.13c  128.5-130 
°C. Published data10b,13c were in accordance with ours:   1H NMR (CDCl3, 400 MHz): δ 7.74 
(d, J = 15.9 Hz, 1H), 7.45 (d, J = 8.6 Hz, 2H), 6.85 (d, J = 8.6 Hz, 2H), 6.32 (d, J = 15.9 Hz, 
1H), 0.99 (s, 9H), ÷0.23 (s, 6H); 13C NMR (CDCl3, 100 MHz): δ 172.8 (CO), 158.3 (C), 
146.8 (CH), 130.1 (2xCH), 127.4 (C), 120.6 (2xCH), 114.9 (CH), 25.6 (3xCH3), 18.3 (C), 
÷4.4 (2xCH3); IR (KBr) 2928 (m), 2857 (m), 2606 (w), 1682 (s), 1623 (m), 1599 (s), 1573 
(m), 1508 (s), 1471 (m), 1426 (m), 1361 (w), 1334 (m), 1311 (m), 1286 (m), 1258 (s), 1223 
(m), 1168 (m), 1101 (w), 1005 (w), 985 (m), 912 (m), 837 (m), 802 (w), 778 (m), 685 (w), 
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633 (w); Mass spectrum m/z (relative intensity %) 301.1 [M+ Na]+ (100); HRMS (ESI) Calc. 
for C15H22O3NaSi: 301.1230, Found 301.1228. 
4.6. (E)-4-(2-Iodovinyl)-1,2-dimethoxybenzene (7a) 
To a solution of acrylic acid 5a (1.088 g, 5.23 mmol) in MeCN : H2O (19:1, 60 mL) were 
added LiOAc (69 mg, 1.05 mmol) and NIS (1.178 g, 5.23 mmol) at room temperature. The 
orange mixture was stirred at room temperature for 1 h before being concentrated in vacuo on 
silica gel. The crude product was purified by flash column chromatography (petroleum ether: 
EtOAc 5:1) to afford 1.206 g (80%) of product 7a as a white solid. mp 76.6-77.7 °C (hexane). 
1H NMR (CDCl3, 400 MHz): δ 7.35 (d, J = 14.9 Hz, 1H), 6.86-6.80 (m, 3H), 6.65 (d, J = 14.9 
Hz, 1H), 3.89 (s, 3H), 3.88 (s, 3H); 13C NMR (CDCl3, 100 MHz): δ 149.4 (C), 149.0 (C), 
144.5 (CH), 130.9 (C), 119.3 (CH), 110.9 (CH), 108.2 (CH), 73.9 (CH), 55.9 (CH3), 55.8 
(CH3); IR (KBr) 2925 (w), 2833 (w), 1601 (m), 1573 (w), 1514 (s), 1460 (m), 1336 (w), 1305 
(m), 1264 (s), 1180 (m), 1154 (m), 1136 (s), 1024 (m), 949 (s), 855 (w), 811 (w), 764 (m); 
Mass spectrum m/z (relative intensity %) 312.9 [M+Na]+ (100); HRMS (ESI) Calc. for 
C10H11O2INa: 312.9696, Found 312.9699. 
4.7. (E)-1-(2-Iodovinyl)-4-methoxybenzene (7b) 
To a solution of 4-methoxycinnamic acid (1.028 g, 5.77 mmol) in MeCN : H2O (19:1, 60 mL) 
was added LiOAc (77 mg, 1.17 mmol) and NIS (1.291 g, 5.74 mmol) at room temperature. 
The orange mixture was stirred at room temperature for 1 h before concentrated in vacuo on 
silica gel. The crude product was purified by flash column chromatography (petroleum ether: 
EtOAc 19:1) to afford 1.111 g (74%) of product 7b as a beige solid (turned black after 2 days 
in fridge). Published data16 were in accordance with ours: 1H NMR (CDCl3, 400 MHz): δ 7.36 
(d, J = 14.8 Hz, 1H), 7.23 (d, J = 6.8 Hz, 2H), 6.88 (d, J = 6.8 Hz, 2H), 6.63 (d, J = 14.8 Hz, 
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1H), 3.81 (s, 3H); 13C NMR (CDCl3, 100 MHz): δ 159.7 (C), 144.3 (CH), 130.7 (C), 127.3 
(2xCH), 114.1 (2xCH), 73.6 (CH), 55.3 (CH3)  
4.8. (E)-((4-(2-Iodovinyl)-1,2-phenylene)bis(oxy))bis(tert-butyldimethylsilane) (7c) 
To a solution of acrylic acid 5c (693 mg, 1.70 mmol) in MeCN : H2O (19:1, 20 mL) was 
added LiOAc (26 mg, 0.36 mmol) and NIS (385 mg, 1.71 mmol) at room temperature. The 
orange mixture was stirred at room temperature for 3 h, added sodium thiosulphate 
(concentrated, 2-3 drops) and silica gel and concentrated in vacuo. The crude product was 
purified by flash column chromatography (2% EtOAc in petroleum ether) to afford 594 mg 
(71%) of product 7c as a pale pink oil. 1H NMR (CDCl3, 400 MHz): δ 7.28 (d, J = 14.6 Hz, 
1H), 6.77-6.76 (m, 3H), 6.56 (d, J = 14.8 Hz, 1H), 0.99 (s, 9H), 0.98 (s, 9H), 0.20 (s, 12H); 
13C NMR (CDCl3, 100 MHz): δ 147.6 (C), 147.0 (C), 144.5 (CH), 131.5 (C), 121.1 (CH), 
119.6 (CH), 118.6 (CH), 73.7 (CH), 25.9 (6xCH3), 18.5 (C), 18.4 (C), ÷4.0(8) (2xCH3), 
÷4.0(7) (2xCH3); IR (KBr) 2956 (m), 2930 (m), 2895 (w), 2858 (m), 1596 (w), 1561 (m), 
1508 (s), 1472 (m), 1419 (w), 1405 (w), 1362 (w), 1295 (s), 1254 (m), 1234 (m), 1175 (m), 
1124 (w), 983 (w), 906 (m), 839 (s), 781 (m), 685 (w); Mass spectrum m/z (relative intensity 
%) 513.1 [M+Na]+ (100); HRMS (ESI) Calc. for C20H35O2INaSi2: 513.1112, Found 513.1116. 
4.9. (E)-tert-Butyl(4-(2-iodovinyl)phenoxy)dimethylsilane (7d) 
To a solution of acrylic acid 5d (415 mg, 1.49 mmol) in MeCN : H2O (19:1, 20 mL) was 
added LiOAc (20 mg, 0.30 mmol) and NIS (335 mg, 1.49 mmol) at room temperature. The 
orange mixture was stirred at room temperature for 18 h, added sodium thiosulphate 
(concentrated, 2-3 drops) and silica gel and concentrated in vacuo. The crude product was 
purified by flash column chromatography (2% EtOAc in petroleum ether) to afford 396 mg 
(74%) of product 7d as a yellow oil. 1H NMR (CDCl3, 400 MHz): δ 7.35 (d, J = 14.8 Hz, 1H), 
7.17 (d, J = 8.7 Hz, 2H), 6.78 (d, J = 8.6 Hz, 2H), 6.62 (d, J = 14.8 Hz, 1H), 0.98 (s, 9H), 
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÷0.20 (s, 6H); 13C NMR (CDCl3, 100 MHz): δ 156.0 (C), 144.4 (CH), 131.3 (C), 127.2 
(2xCH), 120.3 (2xCH), 73.8 (CH), 25.7 (3xCH3), 18.2 (C), ÷4.4 (2xCH3); IR (KBr) 2956 
(m), 2929 (m), 2858 (m), 1601 (m), 1508 (s), 1472 (m), 1362 (w), 1266 (br. s), 1175 (m), 949 
(w), 914 (s), 839 (m), 800 (w), 781 (m), 682 (w); Mass spectrum m/z (relative intensity %) 
264.9 [M]+ (100); HRMS (ESI) Calc. for C10H11O2BrNa: 264.9835, Found 264.9839. 
4.10. (E)-4-(2-Bromovinyl)-1,2-dimethoxybenzene (6) 
To a solution of acrylic acid 5a (400 mg, 1.92 mmol) in MeCN : H2O (19:1, mL) was added 
LiOAc (25 mg, 0.38 mmol) and NIS (343 mg, 1.92 mmol) at room temperature. The yellow 
mixture was stirred at room temperature for 1 h before concentrated in vacuo on silica gel. 
The crude product was purified by flash column chromatography (petroleum ether: EtOAc 
5:1) to afford 387 mg (83%) of product 6 as a white solid. mp  61.8-63.2 °C (hexane), lit.17 66 
°C. Published data17 were in accordance with ours: 1H NMR (CDCl3, 400 MHz): δ 7.03 (d, J 
= 14.0 Hz, 1H), 6.86-6.80 (m, 3H), 6.62 (d, J = 13.9 Hz, 1H), 3.89 (s, 3H), 3.88 (s, 3H); 13C 
NMR (CDCl3, 100 MHz): δ 149.2 (C), 149.0 (C), 136.7 (CH), 128.9 (C), 119.3 (CH), 111.1 
(CH), 108.4 (CH), 104.2 (CH), 55.9 (CH3), 55.8 (CH3); IR (KBr) 3081 (w), 2953 (w), 2835 
(m), 1602 (m), 1577 (w), 1512 (s), 1461 (m), 1438 (m), 1418 (m), 1328 (w), 1304 (w), 1263 
(s), 1249 (m), 1208 (m), 1193 (m), 1155 (m), 1139 (s), 1037 (m), 1024 (m), 943 (m), 854 (w), 
813 (w), 773 (m), 712 (w); Mass spectrum m/z (relative intensity %) 312.9 [M+Na]+ (100); 
HRMS (ESI) Calc. for C10H11O2INa: 312.9696, Found 312.9699. 
4.11. (Z)-1-((E)-3,4-Dimethoxystyryl)-2,3-bis(tert-butoxycarbonyl)guanidine (9a) 
A vial loaded with compound 8 (80 mg, 0.309 mmol), 6 (51 mg, 0.209 mmol) or 7a (58 mg, 
0.200 mmol), K3PO4 (87 mg, mmol) and CuI (43 mg, mmol) were evacuated and backfilled 
with argon three times. DMEDA (50 µL, 0.46 mmol) and MeCN (1.5 mL) was added and the 
turkish-blue mixture was microwave heated (50 W, 65 °C) for 35 min, cooled and 
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concentrated in vacuo on silica gel. Purification by flash column chromatography (petroleum 
ether: EtOAc 5:1) afforded 41 mg (49%) from 7a, or 26 mg ( 29%) from 6, of product 9a as a 
fluffy white foamy oil. 1H NMR (CDCl3, 400 MHz): δ 11.61 (br s, 1H), 10.26 (d, J = 10.3 Hz, 
1H), 7.52 (dd, J = 14.6, 10.4 Hz, 1H), 6.92 (d, J = 1.9 Hz, 1H), 6.83 (dd, J = 8.3, 1.9 Hz, 1H), 
6.78 (d, J = 8.3 Hz), 6.12 (d, J = 14.6 Hz, 1H), 3.90 (s, 3H), 3.87 (s, 3H), 1.54 (s, 9H), 1.53 (s, 
9H); 13C NMR (CDCl3, 100 MHz): δ 163.0 (CO), 153.1 (C=N), 152.8 (C), 149.0 (C), 148.3 
(C), 128.7 (C), 120.6 (CH), 119.4 (CH), 115.1 (CH), 111.1 (CH), 108.0 (CH), 83.9 (C), 80.0 
(C), 56.0 (OCH3), 55.9 (OCH3), 28.2 (3xCH3), 28.0 (3xCH3); IR (KBr) 3263 (w), 2977 (m), 
2932 (m), 1720 (m), 1638 (br. s), 1614 (br. s), 1513 (m), 1454 (m), 1407 (br. m), 1368 (m), 
1310 (s), 1265 (m), 1233 (m), 1206 (m), 1153 (br. s), 1104 (s), 1057 (m), 1027 (m), 943 (br. 
w), 854 (w), 803 (w), 771 (w); Mass spectrum m/z (relative intensity %) 444.2 [M+Na]+ 
(100); HRMS (ESI) Calc. for C21H31O6N3Na: 444.2105, Found 444.2101.  
4.12. (Z)-1-((E)-4-Methoxystyryl)-2,3-bis(tert-butoxycarbonyl)guanidine (9b) 
A vial loaded with compound 8 (80 mg, 0.309 mmol), 7b (53 mg, 0.204 mmol), K3PO4 (87 
mg, 0.410 mmol) and CuI (43 mg, 0.226 mmol) were evacuated and backfilled with argon 
three times. DMEDA (50 µL, 0.46 mmol) and MeCN (1.5 mL) was added and the turkish-
blue mixture was microwave heated (50 W, 65 °C) for 35 min, cooled and concentrated in 
vacuo on silica gel. Purification by flash column chromatography (petroleum ether: EtOAc 
5:1) afforded 36 mg (45%) of product 9b as a fluffy white foamy oil. 1H NMR (CDCl3, 400 
MHz): δ 11.57 (s, 1H), 10.20 (d, J = 10.4 Hz, 1H), 7.52 (dd, J = 14.6, 10.4 Hz, 1H), 7.27 (dd, 
J = 8.8 Hz, 2H), 6.82 (dd, J = 8.8 Hz, 2H), 6.12 (d, J = 14.6 Hz, 1H), 3.79 (s, 3H), 1.53 (s, 
9H), 1.52 (s, 9H); 13C NMR (CDCl3, 100 MHz): δ 163.0 (C), 158.6 (C=N), 153.1 (C), 153.1 
(C), 152.7 (C), 128.4 (C), 127.0 (2xCH), 120.6 (CH), 114.6 (CH), 114.0 (2xCH), 83.8 (C), 
79.8 (C), 55.2 (OCH3), 28.2 (3xCH3), 28.0 (3xCH3); IR (KBr) 3267 (w), 3093 (w), 2978 (m), 
2932 (w), 1722 (m), 1639 (br. s), 1615 (br. s), 1509 (w), 1408 (br. m), 1368 (m), 1319 (s), 
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1293 (m), 1247 (s), 1155 (s), 1112 (s), 1057 (m), 1030 (m), 945 (w), 843 (w), 805 (w); Mass 
spectrum m/z (relative intensity %) 392.2 [M]+ (100); HRMS (ESI) Calc. for C20H30O5N3: 
392.2176, Found 392.2176. 
4.13. (Z)-1-((E)-3,4-Bis((tert-butyldimethylsilyl)oxy)styryl)-2,3-bis(tert-
butoxycarbonyl)guanidine (9c) 
A vial loaded with compound 8 (102 mg, 0.393 mmol), 7c (129 mg, 0.263 mmol), K3PO4 
(112 mg, 0.528 mmol) and CuI (55 mg, 0.289 mmol) were evacuated and backfilled with 
argon three times. DMEDA (60 µL, 0.55 mmol) and MeCN (1.5 mL) was added and the 
turkish-blue mixture was microwave heated (50 W, 65 °C) for 35 min, cooled and 
concentrated in vacuo on silica gel. Purification by flash column chromatography (petroleum 
ether: EtOAc 5:1) afforded 74 mg (45%) of product 9c as a fluffy white foamy oil. 1H NMR 
(CDCl3, 400 MHz): δ 11.6 (s, 1H), 10.18 (d, J = 10.3 Hz, 1H), 7.45 (dd, J = 14.6, 10.4 Hz, 
1H), 6.87 (dd, J = 8.3, 2.1 Hz, 1H), 6.73 (dd, J = 5.4, 3.2 Hz, 2H), 6.05 (d, J = 14.6 Hz, 1H), 
1.53 (s, 9H), 1.52 (s, 9H), 0.98 (s, 9H), 0.97 (s, 9H), 0.19 (s, 6H), 0.18 (s, 9H); 13C NMR 
(CDCl3, 100 MHz): δ 163.0 (C), 153.1 (CO), 152.7 (CO), 146.7 (C), 146.1 (C), 129.4 (C), 
121.2 (CH), 120.8 (CH), 119.5 (CH), 118.7 (CH), 115.0 (CH), 83.8 (C), 79.8 (C), 28.2 
(3xCH3), 28.0 (3xCH2), 25.9 (6xCH3), 18.5 (C), 18.4 (C), ÷4.1(0) (2xCH3), ÷4.1(1) (2xCH3); 
IR (KBr) 3264 (w), 2958 (m), 2931 (m), 2859 (m), 1721 (m), 1642 (s), 1617 (s), 1563 (m), 
1509 (s), 1473 (m), 1412 (s), 1369 (m), 1316 (s), 1275 (s), 1253 (s), 1232 (m), 1154 (s), 1124 
(m), 1105 (m), 1058 (m), 1029 (w), 983 (w), 940 (w), 908 (m), 840 (m), 806 (m), 781 (m), 
733 (w), 695 (w); Mass spectrum m/z (relative intensity %) 644.4 [M+Na]+ (100); HRMS 





A vial loaded with compound 8 (135 mg, 0.521 mmol), 6d (125 mg, 0.347 mmol), Cs2CO3 
(226 mg, 0.693 mmol) and CuI (73 mg, 0.383 mmol) were evacuated and backfilled with 
argon three times. DMEDA (80 µL, 0.73 mmol) and MeCN (1.5 mL) was added and the 
turkish-blue mixture was microwave heated (50 W, 65 °C) for 35 min, cooled and 
concentrated in vacuo on silica gel. Purification by flash column chromatography (petroleum 
ether: EtOAc 5:1) afforded 63 mg (37%) of product 9d as a fluffy white foamy oil. 1H NMR 
(CDCl3, 400 MHz): δ 11.56 (s, 1H), 10.19 (d, J = 10.4 Hz, 1H), 7.51 (dd, J = 14.6, 10.4 Hz, 
1H), 7.21 (d, J = 8.6 Hz, 2H), 6.75 (d, J = 8.6 Hz, 2H), 6.11 (d, J = 14.6 Hz, 1H), 1.52 (s, 9H), 
1.52 (s, 9H), 0.97 (s, 9H), ÷0.19 (s, 6H); 13C NMR (CDCl3, 100 MHz): δ 163.1 (C), 154.8 
(C), 153.1 (CO), 152.8 (CO), 129.0 (C), 127.0 (2xCH), 120.8 (CH), 120.2 (2xCH), 114.8 
(CH), 83.9 (C), 80.1 (C), 28.2 (3xCH3), 28.1 (3xCH3), 25.7 (3xCH3), 18.2 (C), ÷4.4 
(2xCH3); IR (KBr) 2929 (m), 1720 (m), 1639 (s), 1615 (s), 1407 (m), 1368 (m), 1316 (s), 
1252 (s), 1154 (s), 1108 (s), 1057 (m), 912 (w), 839 (w), 805 (w), 780 (w); Mass spectrum 
m/z (relative intensity %) 492.7 [M+Na]+ (100); HRMS (ESI) Calc. for C25H42O5N3Si: 
492.2888, Found 492.2897. 
4.15. Tubastrine (1) 
To a solution of compound 9c (53 mg, 0.085 mmol) in THF (3 mL) was added TBAF (1 M in 
THF 0.18 mL, 0.18 mmol) dropwise at ÷10 °C (brine/ice). The green solution was stirred for 
5 min, quenched with NH4Cl (sat., 10 mL) and extracted with Et2O (3 x 15 mL). The organic 
layer was dried over MgSO4, filtered and concentrated in vacuo. The crude product was 
purified by flash column chromatography (petroleum ether: EtOAc 2:1) to afford 32 mg 
(97%) of product as a fluffy white foamy oil. 1H NMR (CDCl3, 400 MHz): δ 11.56 (s, 1H), 
10.19 (d, J = 10.4 Hz, 1H), 7.35 (dd, J = 14.4, 10.4 Hz, 1H), 6.84 (d, J = 2.0 Hz, 1H), 6.77 (d, 
J = 8.2 Hz, 1H), 6.60 (dd, J = 8.2, 2.0 Hz, 1H), 5.99 (d, J = 14.5 Hz, 1H), 1.52 (s, 9H), 1.51 
(s, 9H); 13C NMR (CDCl3, 100 MHz): δ 162.6 (C), 153.0 (C), 152.9 (C), 143.7 (C), 143.5 
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(C), 128.6 (C), 120.2 (CH), 119.7 (CH), 115.6 (CH), 115.3 (CH), 111.5 (CH), 84.1 (C), 80.5 
(C), 28.2 (3xCH3), 28.0 (3xCH3). A solution of the tubastrine precursor (26 mg, 0.066 mmol) 
and TFA (0.02 mL, 0.27 mmol) in MeCN (2 mL) was microwave heated (100 W, 100 °C) for 
20 min, cooled to room temperature and concentrated in vacuo. The crude product was 
purified by a C18-column using water : MeCN gradient to obtain 14 mg (67% (64% from 9c)) 
as a fluffy pale yellow foamy oil. Published data1-3 were in accordance with ours: 1H NMR 
(CD3OD, 400 MHz): δ 6.93 (d, J = 13.9 Hz, 1H), 6.82 (s, 1H), 6.70 (s, 2H), 6.16 (d, J = 13.9 
Hz, 1H); 13C NMR (CD3OD, 100 MHz): δ 156.1 (C), 146.6 (C), 146.2 (C), 128.7 (C), 120.0 
(C), 119.0 (CH), 118.3 (CH), 116.5 (CH), 113.8 (CH); Mass spectrum m/z (relative intensity 
%) 194.2 [M]+ (100); HRMS (ESI) Calc. for C9H11O2N3: 194.0924, Found 194.0924. 
 
4.16. 3-Dehydroxy-tubastrine (2) 
To a solution of compound 9d (47 mg, 0.096 mmol) in THF (3 mL) was added TBAF (1 M in 
THF, 0.12 mL, 0.12 mmol) dropwise at room temperature. The yellow solution was stirred for 
30 min, quenched with water (10 mL) and extracted with Et2O (3 x 15 mL). The organic layer 
was dried over MgSO4, filtered and concentrated in vacuo. The crude product was purified by 
flash column chromatography (petroleum ether: EtOAc 2:1) to afford 33 mg (92%) of product 
as a fluffy white foamy oil. 1H NMR (CDCl3, 400 MHz): δ 11.55 (s, 1H), 10.22 (d, J = 10.3 
Hz, 1H), 7.40 (dd, J = 14.4, 10.3 Hz, 1H), 7.03 (d, J = 8.1 Hz, 2H), 6.82 (br.s, 1H), 6.75 (d, J 
= 7.9 Hz, 2H), 6.08 (d, J = 14.5 Hz, 1H), 1.52 (s, 9H), 1.51 (s, 9H); 13C NMR (CDCl3, 100 
MHz): δ 162.8 (C), 155.4 (C), 153.1 (C), 152.8 (C), 127.8 (C), 127.2 (2xCH), 120.2 (CH), 
115.7 (2xCH), 115.4 (CH), 84.0 (C), 80.2 (C), 28.2 (3xCH3), 28.1 (3xCH3). A solution of the 
3-dehydroxy tubastrine precursor (27 mg, 0.072 mmol) and TFA (0.02 mL, 0.27 mmol) in 
MeCN (2 mL) was microwave heated (100 W, 100 °C) for 20 min, cooled to room 
temperature and concentrated in vacuo. The crude product was purified by a C18-column 
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using water : MeCN gradient to obtain 15 mg (68% (61% from 9d)) as a fluffy pale yellow 
foamy oil. Published data4,5 were in accordance with ours: 1H NMR (CD3OD, 400 MHz): δ 
7.20 (d, J = 8.5 Hz, 2H), 6.98 (d, J = 14 Hz, 1H), 6.72 (d, J = 8.7 Hz, 2H), 6.22 (d, J = 14.0 
Hz, 1H); 13C NMR (CD3OD, 100 MHz): δ 158.1 (C), 156.0 (C), 128.1(1) (CH), 128.1(0) (C), 
120.0 (2xCH), 118.0 (CH), 116.6 (CH); Mass spectrum m/z (relative intensity %) 178.2 [M]+ 
(100); HRMS (ESI) Calc. for C9H11ON3: 178.0975, Found 178.0972 which is in accordance 
with literature.4,5 
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